Your browser doesn't support javascript.
loading
Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016].
Owen, Carolyn; Banerji, Versha; Johnson, Nathalie; Gerrie, Alina; Aw, Andrew; Chen, Christine; Robinson, Sue.
Affiliation
  • Owen C; Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB T2N 4N2, Canada. Electronic address: Carolyn.Owen@albertahealthservices.ca.
  • Banerji V; Department of Hematology and Medical Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
  • Johnson N; Department of Medicine, Jewish General Hospital, Montréal, QC H3T 1E2, Canada.
  • Gerrie A; Division of Medical Oncology, Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Aw A; Division of Hematology, The Ottawa Hospital, Ottawa, Ontario K1Y 4E9, Canada.
  • Chen C; Department of Medical Oncology, University of Toronto, and Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
  • Robinson S; Division of Hematology, Dalhousie University, and qeii Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
Leuk Res ; 128: 107073, 2023 May.
Article in En | MEDLINE | ID: mdl-37019803
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2023 Type: Article